Angelo Gordon & Co’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Angelo Gordon & Co’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50,000	Closed	-$19K	–	120
2022 Q4	$159K	Hold	50,000	–	–	0.03%	159
2022 Q3	$292K	Hold	50,000	–	–	0.05%	200
2022 Q2	$451K	Hold	50,000	–	–	0.05%	176
2022 Q1	$590K	Buy	+50,000	New	+$27.3K	0.07%	150

Other funds holding DRTSW

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

ACM

Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Angelo Gordon & Co's DRTSW Position: Q1 2023 in Review

Angelo Gordon & Co sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2023, closing a stake of 50,000 shares — an estimated $19K sold.

Angelo Gordon & Co first reported a position in DRTSW in Q1 2022 and held it in 4 quarters. The position peaked at $590K in Q1 2022. 32 funds tracked by Wall St. Rank hold DRTSW as of Q1 2023.

Angelo Gordon & Co reported no remaining Alpha Tau Medical Warrant position as of Q1 2023 after selling out during the quarter.
Angelo Gordon & Co sold 50,000 Alpha Tau Medical Warrant shares in Q1 2023, an estimated $19K.
Angelo Gordon & Co first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 4 quarters.
Angelo Gordon & Co's Alpha Tau Medical Warrant position peaked at $590K in Q1 2022.
32 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2023.

Based on Angelo Gordon & Co's 13F filing for Q1 2023, filed 15 May 2023.